ATE132374T1 - Verhütung und behandlung einer retrovirenkrankheit - Google Patents

Verhütung und behandlung einer retrovirenkrankheit

Info

Publication number
ATE132374T1
ATE132374T1 AT88906347T AT88906347T ATE132374T1 AT E132374 T1 ATE132374 T1 AT E132374T1 AT 88906347 T AT88906347 T AT 88906347T AT 88906347 T AT88906347 T AT 88906347T AT E132374 T1 ATE132374 T1 AT E132374T1
Authority
AT
Austria
Prior art keywords
immunogen
retrovirus
hiv
infectious
useful
Prior art date
Application number
AT88906347T
Other languages
English (en)
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Application granted granted Critical
Publication of ATE132374T1 publication Critical patent/ATE132374T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
AT88906347T 1987-06-10 1988-06-09 Verhütung und behandlung einer retrovirenkrankheit ATE132374T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US20075288A 1988-05-31 1988-05-31

Publications (1)

Publication Number Publication Date
ATE132374T1 true ATE132374T1 (de) 1996-01-15

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88906347T ATE132374T1 (de) 1987-06-10 1988-06-09 Verhütung und behandlung einer retrovirenkrankheit

Country Status (14)

Country Link
EP (3) EP0602761A1 (de)
JP (1) JPH0720880B2 (de)
AT (1) ATE132374T1 (de)
AU (1) AU612383B2 (de)
CA (1) CA1336407C (de)
DE (1) DE3854857T2 (de)
DK (1) DK56389A (de)
FI (1) FI95871C (de)
IL (1) IL86675A (de)
NO (1) NO175846C (de)
OA (1) OA09037A (de)
RU (1) RU2111010C1 (de)
UA (1) UA27716C2 (de)
WO (1) WO1988009670A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI885441L (fi) * 1987-03-23 1988-11-23 Hiver Ltd Nya vaccin.
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
WO1990015133A1 (fr) * 1989-05-30 1990-12-13 Nippon Zeon Co., Ltd. Procede de production de structures de noyau de retrovirus et particules ainsi produites
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
DE69515028T2 (de) * 1994-03-22 2000-06-29 The Immune Response Corp., Carlsbad Die hocheffiziente herstellung und isolierung von viruspartikeln
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.
WO2003016337A1 (en) * 2001-08-07 2003-02-27 Medestea Internazionale S.R.L. Isolated polypeptides based on the neutralizing epitope of the p17 protein of hiv useful as vaccines, and neutralizing anti-p17 antibodies which specifically recognize said neutralizing epitope

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
DE3588134T2 (de) * 1984-12-24 1997-03-20 Genentech Inc Fusionen von AIDS-verwandten Polypeptiden
ES8706824A1 (es) * 1985-04-08 1987-07-01 Genetic Systems Corp Un metodo para preparar proteinas que son inmunologicamente reactivas con anticuerpos para virus asociados con linfadenopatia.
FI861626A7 (fi) * 1985-04-19 1986-10-20 Hoffmann La Roche Foervaervat immunbristsyndrom (aids) -relaterat viralt rekombinant hoeljeprotein samt ett testfoerfarande foer aids.
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0250128A3 (de) * 1986-06-18 1988-06-08 American Registry of Pathology Von AIDS-Patienten isoliertes Virus
CA1341277C (en) * 1987-03-16 2001-07-31 Roland Keith Mcgready Anti-paratopic antibody and a method of its manufacture

Also Published As

Publication number Publication date
JPH0720880B2 (ja) 1995-03-08
OA09037A (en) 1991-03-31
NO890565L (no) 1989-02-09
IL86675A (en) 1993-04-04
EP0317622A1 (de) 1989-05-31
RU2111010C1 (ru) 1998-05-20
CA1336407C (en) 1995-07-25
DK56389D0 (da) 1989-02-08
DE3854857D1 (de) 1996-02-15
NO175846B (de) 1994-09-12
EP0602761A1 (de) 1994-06-22
FI890603A0 (fi) 1989-02-08
AU612383B2 (en) 1991-07-11
FI95871B (fi) 1995-12-29
DK56389A (da) 1989-02-08
WO1988009670A1 (en) 1988-12-15
AU1962688A (en) 1989-01-04
NO890565D0 (no) 1989-02-09
EP0317622A4 (de) 1990-05-14
UA27716C2 (uk) 2000-10-16
FI890603L (fi) 1989-02-08
DE3854857T2 (de) 1996-08-22
JPH02500440A (ja) 1990-02-15
EP0685236A1 (de) 1995-12-06
FI95871C (fi) 1996-04-10
NO175846C (no) 1994-12-21
EP0317622B1 (de) 1996-01-03

Similar Documents

Publication Publication Date Title
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
ATE418562T1 (de) Ctl epitope des epstein-barr virus
ATE362379T1 (de) Induktion rev- und tat-spezifischer zytotoxischer t-zellen zur prävention und behandlung einer infektion durch humanen immundefizienz-virus (hiv)
EP0330359A3 (de) Zusammensetzung, verwendbar zur Diagnose und Behandlung von HIV-I-Infektion
BR0107972A (pt) Uso de uma proteìna ou polinucleotìdeo tat do hiv, nef do hiv, ou tat do hiv ligado(a) a uma proteìna ou polinucleotìdeo nef do hiv (nef-tat), e de uma proteìna ou polinucleotìdeo gp120 do hiv, método para imunizar um ser humano contra o hiv, e, composição de vacina para o uso humano
HUP9801560A1 (hu) Szaponint és szterint tartalmazó vakcinák
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
EP0726758A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozythen gerichetetgegen das hepatitis b-virus
OA08652A (fr) Compositions, vaccin et anticorps monoclonaux utiles pour le traitement des affections par le virus HIV et procédés de production de ces anticorps et de diagnostic de la présence de ce virus.
BG98522A (bg) Пептиди, индуциращи цитотоксичен т-лимфоцитен отговор на вируса на хепатит в
ATE132374T1 (de) Verhütung und behandlung einer retrovirenkrankheit
EP0687182A4 (de) Peptide zum induzieren einer antwort der zytotoxischen t-lymphozyten gerichtet gegen das hepatitis b virus
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
DE69707680D1 (de) Caprin arthritis-enzephalitis virus enthaltende vakzine und verwendung zur immunschutz gegen hiv-1 infektion
EP1073461A4 (de) Virale chimären aus caev und hiv-1 genetischen elementen
WO1996030045A1 (en) Vaccine for the immunoprophylaxis of the infection from feline immunodeficiency virus in the domestic cat
EA199700353A1 (ru) Композиция и способ для определения приобретенного синдрома иммунодефицита, способ приготовления названной композиции
DE68918127D1 (de) Peptidbehandlung von hartnäckigen Infektionskrankheiten.
EP0309898A3 (de) Methode zur Induktion einer zytotoxischen T-Zell-Antwort
IT1233419B (it) Peptidi sintetici immunologicamente attivi utili per la preparazione di un vaccino antimalaria
Osterhaus et al. Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections
SU1739559A1 (ru) Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee